Intrinsic Therapeutics
Providing durable solutions to herniated disc patients with Barricaid technology.
| Date | Investors | Amount | Round |
|---|---|---|---|
$850k | Series A | ||
$7.2m | Series B | ||
$25.0m | Series C | ||
$21.0m | Series D | ||
$18.0m | Late VC | ||
$28.0m | Debt | ||
$52.0m | Series E | ||
| N/A | $38.4m | Late VC | |
| Total Funding | $162m | ||